State Of Wyoming Alx Oncology Holdings Inc Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.89 - $19.46 $1,784 - $5,896	-303 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$13.65 - $22.06 $1,269 - $2,051	93 Added 44.29%	303 $5,000
Q4 2021 Feb 11, 2022	BUY	$21.49 - $74.4 $666 - $2,306	31 Added 17.32%	210 $5,000
Q3 2021 Feb 11, 2022	SELL	$52.51 - $80.91 $6,353 - $9,790	-121 Reduced 40.33%	179 $13,000
Q2 2021 Feb 11, 2022	BUY	$52.2 - $75.23 $9,604 - $13,842	184 Added 158.62%	300 $16,000
Q1 2021 Feb 08, 2022	BUY	$62.84 - $87.68 $7,289 - $10,170	116 New	116 $9,000

101

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $66M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.